Oculogenex

Oculogenex is a biotechnology company that uses gene therapy to improve the vision of patients with retinal degenerative diseases. Headquartered in California, the company is developing a gene therapy method to halt the central vision degeneration in patients with age-related macular degeneration. This therapy has the potential to significantly enhance the quality of life for patients suffering from blinding retinal diseases who currently have no treatment options.